Neovasc Inc.

Recent News

  • Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021

    Vancouver, British Columbia--(Newsfile Corp. - July 27, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the second quarter ended June 30, 2021 on Tuesday, August 10 2021. Neovasc's President and Chief Executive Officer, Fred Colen, and Chris Clark, Chief Financial Officer, will host a conference call to review the Company's results at 4:30 pm EDT.Interested parties may access the conference call by dialing (877)-407-9208 or (201)-493-6784 (International) and reference Conference ID 13721306. Participants wishing to...

    2021-07-27 9:05 AM EDT
  • Neovasc Announces New Appointments in Regulatory and Clinical Leadership

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 13, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has appointed Lisa Becker as Vice President, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as Vice President, Clinical Affairs."Neovasc's Regulatory and Clinical teams will be well strengthened with the additions of Lisa and Sarah, who bring tremendous experience in regulatory and clinical affairs to the overall Neovasc team," said Fred Colen, President and...

    2021-07-13 9:05 AM EDT
  • Largest Real-World Registry Supporting Neovasc Reducer(TM) Safety and Efficacy Outcomes Published in International Journal of Cardiology

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 18, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the publication of an article entitled, "Safety and Efficacy of Coronary Sinus Narrowing in Chronic Refractory Angina: Insights from the RESOURCE Study" in the International Journal of Cardiology.The article, authored by Francesco Ponticelli, M.D., Maria Cecilia Hospital, Cotignola, Italy, describes long-term outcomes of patients suffering from refractory angina treated with the Neovasc Reducer™ ("Reducer") system. The RESOURCE stu

    2021-06-18 9:05 AM EDT
  • Neovasc Provides Corporate Update

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Company has implemented a series of strategic initiatives focused on enhancing current shareholder value, minimizing dilution, extending its cash runway well into 2024, focusing investments on near term value drivers, and more deeply reviewing the Company's core business activities.Neovasc Reducer™The Company is focused on expanding reimbursement and increasing revenues in international markets for the Neovasc Reducer™...

    2021-06-10 3:29 PM EDT
  • Neovasc Reducer System Receives First National Reimbursement in Europe

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 7, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Neovasc Reducer® ("Reducer") system has been granted national reimbursement in England as a result of being included in the High-Cost Tariff Excluded Devices (HCTED) national catalogue.The National Health Service England (NHS England) has a nationwide purchase and supply system for specific categories of high-cost tariff-excluded medical devices used in specialized services designed to support the accelerated...

    2021-06-07 9:05 AM EDT
  • Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

    Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 3, 2021 in Vancouver, B.C. (the "Meeting").At the Meeting, the shareholders of the Company (the "Shareholders") re-elected board members Steven Rubin, Paul Geyer, Doug Janzen, Norman Radow, Alexei Marko and Fred Colen to serve in office until the next...

    2021-06-03 4:52 PM EDT
  • Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 25, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00...

    2021-05-25 4:05 PM EDT
  • Neovasc Provides Update on German Litigation

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 20, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") reported today that the Higher Regional Court in Munich, Germany has upheld the first instance judgment of the Regional Court Munich of June 16, 2017, in which the court had found that Edwards Lifesciences LLC ("Edwards") had contributed in part to the invention of the Tiara™ and awarded to Edwards co-entitlement rights to the disputed Tiara™ European patent...

    2021-05-20 4:05 PM EDT